Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study
- Written by PR Newswire
 |
Further secures Brii's rights in BRII-179 with full control of intellectual property, future manufacturing and supply
Several combination treatment studies containing BRII-179 have quickly started to carry forward the Company's strategy for HBV functional cure
DURHAM, N.C. and BEIJING, Dec. 31, 2024 /PRNewswire/ -- Brii Biosciences...
